406MO Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC).

Authors :: Tarazona, N.
Martín-Arana, J.
Tébar-Martínez, R.
Lombardi, P.
Moragón, S.
Zuñiga, S.
Rentero-Garrido, P.
Carbonell-Asins, J.A.
Gambardella, V.
Huerta, M.
Roselló, S.
Martínez-Ciarpaglini, C.
Alfaro-Cervello, C.
Moro, D.
Ferrer-Martínez, A.
Ponce, M.
Peña, A.
Espí, A.
Roda, D.
Cervantes, A.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS413-S414. 2p.
Publication Year :: 2020

Full Text Access

Tools